Minaris Regenerative Medicine
Minaris Regenerative Medicine, is a wholly owned subsidiary of Showa Denko Materials, Co. representing its Regenerative Medicine Business Sector. Its vision is a world in which transformative cell-based therapeutics are accessible to all, and its mission is to provide its clients with high-quality, scalable, innovative, reliable and cost-efficient manufacturing platforms and services to advance commercialization of cellular therapies.
Minaris Regenerative Medicine includes contract development and manufacturing organization (CDMO) services, at current Good Manufacturing Practices (cGMP) standards, including clinical and commercial manufacturing, manufacturing development, and technology development. Minaris Regenerative Medicine operates three cGMP manufacturing facilities in the U.S. – two in Allendale, New Jersey (headquarters) and one in Mountain View, California. Outside of the U.S, the Showa Denko Materials, Co. Business Sector extends to a facility in Yokohama, Japan and apceth Biopharma, based in Munich, Germany.
We have 20 years of exclusive cell therapy experience including serving 125+ clients, completing 50+ technology transfers, and manufacturing therapeutics that have treated 7,500+ patients.
